Pentamidine dosage: A base/salt confusion

PLoS Neglected Tropical Diseases

Volumn 2, Issue 5, 2008, Pages

  Dorlo, Thomas P C ^a   Kager, Piet A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMIDINE DERIVATIVE; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PENTAMIDINE MESYLATE; ANTIPROTOZOAL AGENT; ANTITRYPANOSOMAL AGENT;

AFRICAN TRYPANOSOMIASIS; ANTIMICROBIAL ACTIVITY; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG LABELING; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; HUMAN; LEISHMANIASIS; LOW DRUG DOSE; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS; CHEMISTRY;

ANTIPROTOZOAL AGENTS; GUIDELINES AS TOPIC; HUMANS; LEISHMANIASIS; PENTAMIDINE; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN;

EID: 48949118066     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000225     Document Type: Article

References (18)

1. World Health Organization (WHO) (1962) WHO Expert Committee on Trypanosomiasis: first report. WHO Technical Report Series, no. 247. Geneva: World Health Organization.
2. Food and Agriculture Organization (FAO), World Health Organization (WHO) (1969) African trypanosomiasis: report of a Joint FAO/WHO Expert Committee. WHO Technical Report Series, no. 434. Geneva: World Health Organization.
3. World Health Organization (WHO), Food and Agriculture Organization (FAO) (1979) The African trypanosomiases: report of a Joint WHO Expert Committee and FAO Expert Consultation. WHO Technical Report Series, no. 635. Geneva: World Health Organization.
4. World Health Organization (WHO) (1986) Epidemiology and control of Affican trypanosomiasis: report of a WHO Expert Committee. WHO Technical Report Series, no. 739. Geneva: World Health Organization.
5. World Health Organization (WHO) (1995) Drugs used in parasitic diseases. Geneva: World Health Organization.
6. World Health Organization (WHO) (1998) Control and surveillance of African trypanosomiasis: report of a WHO Expert Committee. WHO Technical Report Series, no. 881. Geneva: World Health Organization.
7. World Health Organization (WHO) (2003) Report of the Scientific Working Group meeting on African typanosomiasis. Geneva: World Health Organization.
8. Médecins Sans Frontières (2007) Clinical Guidelines. Available through; http://www.refbooks. msf.org/msf_docs/en /MSFdocMenu_en.pdf. Accessed 22 January 2008.
9. Manson-Bahr P (1966) Manson's tropical diseases. London: Baillière, Tindall & Cassell.
10. Wilcocks C, Manson-Bahr P (1972) Manson's Tropical Diseases. London: Baillière Tindall.
11. Balasegaram M, Harris S, Checchi F, Harnel C, Karunakara U (2006) Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo. Bull World Health Organ 84: 777-782.
12. Eperon G, Schmid C, Loutan L, Chappuis F (2007) Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children. Acta Trop 101: 31-39.
13. World Health Organization (WHO) (1990) Control of the leishmaniases: report of a WHO Expert Committee. WHO Technical Report Series, no. 793. Geneva: World Health Organization.
14. World Health Organization (WHO) (1984) The leishmaniases: report of a WHO Expert Committee. WHO Technical Report Series, no. 701. Geneva: World Health Organization.
15. Bryceson A (1987) Therapy in man. In: Peters W, killick-Kendrick R, eds. The leishmaniases in biology and medicine. Volume II: clinical aspects and control. London: Academic Press. pp 847-907.
16. Delobel P, Pradinaud R (2003) Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis. J Antimicrob Chemother 51: 1319-1320.
17. Jha SN, Singh NK, Jha TK (1991) Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial. J Assoc Physicians India 39: 314-316.
18. Budavari S (1996) The Merck Index. Whitehouse Station (Newjerscy): Merck & Co.